New to biotechs, but like what I see in IMU and just want to find a cure for cancer - and make some dollars. Is it possible IMU as the senior partner in this relationship ended the collaboration because ALA was outperforming IMU in the research. Last February our CEO gave an update that the in vitro research was looking promising - what’s gone wrong ?
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update, page-18
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $160.0K | 3.048M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 882045 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 457736 | 5 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |